By: Michael Lim, PharmD Candidate c/o 2020 - In an era of widespread pharmaceutical innovation, the rise of biological products…
By: Karen Chen, PharmD Candidate c/o 2019 - Ibalizumab-uiyk (Trogarzo®) is specifically indicated for the treatment of human immunodeficiency virus…
By: Jonathan Mercado, PharmD Candidate c/o 2019 - In November of 2017, the FDA approved the first drug to contain…
By: Yeonah Suk, PharmD Candidate c/o 2020 - Despite the $107 billion a year cancer drug industry there is no…
By: Gabrielle Flavoni, PharmD Candidate c/o 2018 - This past November, the ACC/AHA released a new definition for the word…
By: Michelle Huang, PharmD Candidate c/o 2021 - In the midst of countless chronic diseases that we face today, one…
By: Katharine Russo, PharmD Candidate c/o 2021 - With the continued increase of antibiotic resistant diseases, scientists are calling this…
By: Katharine Russo, PharmD Candidate c/o 2021 - The DEA announced in August 2017 that 2018 would bring strict manufacturing…
By: Katie Lee, PharmD Candidate c/o 2019 - In 2015, FDA approved evolocumab (Repatha ®), a human monoclonal antibody of…
By: Anna Diyamandoglu, PharmD Candidate c/o 2020 - The specificity of individuals’ genetic makeup has been one of the primary…